The global market for tissue engineering and regeneration was valued at $4.8 billion in 2024 and is estimated to increase from $5.4 billion in 2025 to reach $9.8 billion by 2030, at a compound annual growth rate (CAGR) of 12.8% from 2025 through 2030.
The North American market for tissue engineering and regeneration was valued at $2.1 billion in 2024 and is estimated to increase from $2.4 billion in 2025 to reach $4.5 billion by 2030, at a CAGR of 13.3% from 2025 through 2030.
The Asia-Pacific market for tissue engineering and regeneration was valued at $888.4 million in 2024 and is estimated to increase from $1 billion in 2025 to reach $2.1 billion by 2030, at a CAGR of 15.5% from 2025 through 2030.
Report Scope
The report provides an overview of the global tissue engineering and regeneration market and analyzes market trends. It includes global revenue ($ million) using 2024 as the base year, estimated data for 2025, and projected data for 2026 through 2030.
The market is segmented into product type, material, and application. By product, the market is categorized into scaffolds and tissue grafts. By material, the market is segmented into biologically derived materials and synthetic materials. Based on application, the market is segmented into orthopedic and musculoskeletal disorders, dermatology and wound care, dental disorders, cardiovascular diseases, and others. Geographical regions covered in this study are North America (the U.S., Canada, and Mexico), Europe (Germany, the U.K., Italy, France, and the Rest of Europe), Asia-Pacific (China, Japan, India, and the Rest of Asia-Pacific), the Middle East and Africa (MEA), and South America, focusing on all the major countries in these regions.
The report focuses on the significant driving trends and challenges that affect the market and vendor landscape. It analyzes environmental, social and corporate governance (ESG) developments and discusses emerging technologies related to the market.
The report concludes by analyzing the competitive landscape and providing the ranking/share of key global tissue engineering and regeneration companies. It also contains a dedicated section of company profiles that covers details such as overview, key financials, product portfolio and recent developments in major companies.
Report Includes
- 47 data tables and 64 additional tables
- Analyses of the trends in global markets for tissue engineering and regeneration technologies, with historic revenue data from 2022 to 2024, estimates for 2025, and projected CAGRs through 2030
- Estimates of the market's size and revenue prospects, accompanied by a market share analysis by product type, material, application and region
- Facts and figures pertaining to market dynamics, technological advances, regulations and the impact of macroeconomic factors
- Insights derived from Porter's Five Forces model, as well as global supply chain analysis
- Patent analysis, featuring key granted and published patents
- Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, as well as the ESG risk ratings and practices of leading companies
- Analysis of the industry structure, including companies' market shares and rankings, strategic alliances, M&A activity and a venture funding outlook
- Company profiles of major players within the industry, including Organogenesis Inc., Integra LifeSciences, Smith+Nephew, MiMedx Group Inc., and Johnson & Johnson Services Inc.
Table of Contents
Chapter 1 Executive Summary
- Market Outlook
- Scope of Report
- Market Summary
Chapter 2 Market Overview
- Overview
- Porter's Five Forces Analysis in the Tissue Engineering and Regeneration Market
- Potential for New Entrants (Moderate to High)
- Bargaining Power of Suppliers (Moderate to High)
- Bargaining Power of Buyers (High)
- Threat of Substitutes (Low to Moderate)
- Competition in the Industry (High)
- Macroeconomic Factor Analysis
- Aging Population
- Regulatory Environment
- Government Policy and Collaboration
- The U.S. Tariff Scenario
Chapter 3 Market Dynamics
- Market Dynamics
- Market Drivers
- Rising Demand for Regenerative Medicine
- Growing Research and Approvals in Tissue Engineering
- Increasing Venture Capital Funding
- Market Restraints
- High Cost Associated with Treatment
- Complex Regulatory Pathway
- Market Opportunities
- Technological Advances
- Emerging Economies
Chapter 4 Regulatory Landscape
- The U.S.
- Europe
- Asia-Pacific
Chapter 5 Impact of AI Adoption on the Tissue Engineering and Regeneration Market
- Overview
- Case Studies
- Problem
- Solution
- Outcome
- AI Adoption: Trends
- Adoption Trends in North America
- Adoption Trends in Europe
- Adoption Trends in the Rest of the World
- AI Disruption Trends
- Impact of AI on Various Stages of the Value Chain
- Market Spending and Investment Scenario
- VC Investment in AI
Chapter 6 Emerging Technologies and Developments
- Emerging Technologies
- 3D Bioprinting
- Organ-on-a-Chip
- Smart Biomaterial
- Artificial Intelligence
- Clinical Trials Analysis
- Key Takeaways
- Clinical Trials Analysis, by Type of Study
- Clinical Trials Analysis, by Status
- Clinical Trials Analysis, by Phase
- Patent Analysis
- Key Takeaways
- Patents, by Year
- Patents by Top Applicant
- Patents by Top Owner
- Patents by Jurisdiction
Chapter 7 Market Segmentation Analysis
- Segmentation Breakdown
- Market Analysis by Product Type
- Key Takeaways
- Scaffolds
- Biological Scaffolds
- Synthetic Scaffolds
- Grafts
- Allogenic
- Autogenic
- Synthetic
- Xenogeneic
- Market Analysis by Material
- Key Takeaways
- Biologically Derived Material
- Synthetic Material
- Market Analysis by Application
- Key Takeaways
- Orthopedics and Musculoskeletal Disorders
- Dermatology and Wound Care
- Dental Disorders
- Cardiovascular Diseases
- Others
- Geographic Breakdown
- Market Analysis by Region
- Key Takeaways
- North America
- Europe
- Asia-Pacific
- Middle East and Africa (MEA)
- South America
Chapter 8 Competitive Intelligence
- Key Takeaways
- Competitive Landscape
- Global Market Shares of Leading Companies
- Key Developments and Strategies
Chapter 9 Sustainability in Tissue Engineering and Regeneration: An ESG Perspective
- Introduction to ESG
- Sustainability in Tissue Engineering and Regeneration: An ESG Perspective
- Key ESG Issues
- Tissue Engineering and Regeneration ESG Performance Analysis
- Concluding Remarks from BCC
Chapter 10 Appendix
- Methodology
- Sources
- Abbreviations
- Company Profiles
- ABBVIE INC.
- ALICORN MEDICAL PVT. LTD.
- BAXTER
- B. BRAUN SE
- BD
- BIOTISSUE
- INTEGRA LIFESCIENCES
- JOHNSON & JOHNSON SERVICES INC.
- MEDTRONIC
- MIMEDX GROUP INC.
- ORGANOGENESIS INC.
- SMITH+NEPHEW
- STRYKER
- TECNOSS
- ZIMMER BIOMET
- A Few Emerging Start-ups/Market Disruptors
